Human angiogenin, an organogenic protein

Area of Science:

• Biochemistry
• Molecular Biology
• Physiology

Background:

• Angiogenin is a 14 kD protein initially isolated from tumor cells, now recognized as a normal component of human plasma.
• It exhibits potent blood vessel formation-inducing properties on the chick embryo chorioallantoic membrane.
• Chemical analysis reveals homology to pancreatic ribonucleases, indicating a unique ribonucleolytic activity.

Purpose of the Study:

• To characterize the biological and enzymatic activities of angiogenin.
• To investigate the role of placental ribonuclease inhibitor in modulating angiogenin's functions.
• To explore the mechanistic, physiological, and pharmacologic implications of angiogenin inhibition.

Main Methods:

• Isolation and chemical characterization of angiogenin.
• Assay of blood vessel formation on the chick embryo chorioallantoic membrane.
• In vitro protein synthesis inhibition assays.
• Treatment with placental ribonuclease inhibitor.

Main Results:

• Angiogenin demonstrates potent induction of blood vessel formation.
• The protein possesses unique ribonucleolytic activity.
• Angiogenin is a strong inhibitor of in vitro protein synthesis.
• Placental ribonuclease inhibitor effectively abolishes both biological and enzymatic activities of angiogenin.

Conclusions:

• Angiogenin possesses dual functions: inducing angiogenesis and inhibiting protein synthesis.
• Placental ribonuclease inhibitor serves as a critical tool for understanding angiogenin's mechanisms.
• These findings have significant implications for the physiological roles and potential therapeutic targeting of angiogenin.